This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Montana. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Andrea Stierle: Innovator in Antimicrobial Agents
Introduction
Andrea Stierle is a prominent inventor based in Missoula, Montana. She has made significant contributions to the field of antimicrobial agents, particularly through her innovative research and development of macrolide compounds. Her work has the potential to impact the treatment of various microbial infections, including those caused by resistant strains.
Latest Patents
Andrea Stierle holds a patent for "16-methyl-oxacyclohexadecan-2-one and 16-methyl-azacyclohexadecan-2-one derivatives as antimicrobial agents." This patent describes 16-membered macrolide compounds that inhibit the growth of various microbial species. These compounds have utility in the treatment of systemic or topical microbial infections, including methicillin-resistant strains.
Career Highlights
Stierle is affiliated with the University of Montana, where she conducts her research. Her work has garnered attention for its innovative approach to addressing microbial resistance, a growing concern in the medical community. With her expertise, she continues to explore new avenues for developing effective antimicrobial treatments.
Collaborations
Some of her notable coworkers include Donald Stierle and Nigel Priestley. Their collaborative efforts contribute to the advancement of research in antimicrobial agents and enhance the impact of their findings.
Conclusion
Andrea Stierle's contributions to the field of antimicrobial agents exemplify the importance of innovation in addressing public health challenges. Her work not only advances scientific knowledge but also holds promise for improving treatment options for patients facing resistant infections.